Methods of administering anti-OX40 antibodies Grant US-11472883-B2 United States of America 18 Oct 2022
Compositions and methods for the treatment of immune related diseases Grant US-11390678-B2 United States of America 19 Jul 2022
Anti-OX40 antibodies and anti-GITR antibodies Grant US-11359028-B2 United States of America 14 Jun 2022
Vectors comprising nucleic acids encoding anti-OX40 antibodies Grant US-11332536-B2 United States of America 17 May 2022
Gene signatures for determining ICOS expression Grant US-10968277-B2 United States of America 06 Apr 2021
Nucleic acids encoding anti-OX40 antibodies Grant US-10626181-B2 United States of America 21 Apr 2020
Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors Grant US-10626174-B2 United States of America 21 Apr 2020
Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors Grant US-10611836-B2 United States of America 07 Apr 2020
FC BINDING FRAGMENTS COMPRISING OX40 ANTIGNE BINDING SIDE Application WO-2020011974-A1 World Intellectual Property Organisation (WIPO) 16 Jan 2020
Compositions and methods for enhancing the effectiveness of cancer treatment Application JP-2018512397-A Japan 17 May 2018
Composition and methods for the diagnosis of immune related diseases involving the… Grant US-RE46816-E1 United States of America 01 May 2018
Composition and methods for the diagnosis of immune related diseases involving the… Grant US-RE46805-E1 United States of America 24 Apr 2018
Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors Grant US-9873740-B2 United States of America 23 Jan 2018
Composition and methods for the diagnosis of immune related diseases involving the… Grant US-RE46534-E1 United States of America 05 Sep 2017
NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES Application US-20170145093-A1 United States of America 25 May 2017
Compositions and methods for the treatment of immune related diseases Grant US-9499596-B2 United States of America 22 Nov 2016
COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND TIGIT INHIBITORS Application WO-2016073282-A1 World Intellectual Property Organisation (WIPO) 12 May 2016